Issue 1, 2025

A nanoengineered tandem nitroreductase: designing a robust prodrug-activating nanoreactor

Abstract

Nitroreductases are important enzymes for a variety of applications, including cancer therapy and bioremediation. They often require encapsulation to improve stability and activity. We focus on genetically encoded encapsulation of nitroreductases within protein capsids, like encapsulins. Our study showcases the encapsulation of nitroreductase NfsB as functional dimers within encapsulins, which enhances protein activity and stability in diverse conditions. Mutations within the pore region are beneficial for activity of the encapsulated enzyme, potentially by increasing diffusion rates. Cryogenic electron microscopy reveals the overall architecture of the encapsulated dimeric NfsB within the nanoreactor environment and identifies multiple pore states in the shell. These findings highlight the potential of encapsulins as versatile tools for enhancing enzyme performance across various fields.

Graphical abstract: A nanoengineered tandem nitroreductase: designing a robust prodrug-activating nanoreactor

Supplementary files

Article information

Article type
Paper
Submitted
15 Jun 2024
Accepted
03 Oct 2024
First published
04 Nov 2024
This article is Open Access
Creative Commons BY license

RSC Chem. Biol., 2025,6, 21-35

A nanoengineered tandem nitroreductase: designing a robust prodrug-activating nanoreactor

M. Zmyslia, M. J. Capper, M. Grimmeisen, K. Sartory, B. Deuringer, M. Abdelsalam, K. Shen, M. Jung, W. Sippl, H. Koch, L. Kaul, R. Süss, J. Köhnke and C. Jessen-Trefzer, RSC Chem. Biol., 2025, 6, 21 DOI: 10.1039/D4CB00127C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements